Rimke C. Vos

3.6k total citations
107 papers, 1.7k citations indexed

About

Rimke C. Vos is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and General Health Professions. According to data from OpenAlex, Rimke C. Vos has authored 107 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 54 papers in Endocrinology, Diabetes and Metabolism, 37 papers in Epidemiology and 25 papers in General Health Professions. Recurrent topics in Rimke C. Vos's work include Chronic Disease Management Strategies (33 papers), Diabetes Management and Education (32 papers) and Diabetes Management and Research (25 papers). Rimke C. Vos is often cited by papers focused on Chronic Disease Management Strategies (33 papers), Diabetes Management and Education (32 papers) and Diabetes Management and Research (25 papers). Rimke C. Vos collaborates with scholars based in Netherlands, United Kingdom and United States. Rimke C. Vos's co-authors include Guy E.H.M. Rutten, Boon‐How Chew, Jan M. Wit, Hanno Pijl, Sherina Mohd Sidik, Maria-Intí Metzendorf, Rob Scholten, Linda Mellbin, Femke Rutters and Michiel L. Bots and has published in prestigious journals such as JAMA, PLoS ONE and Neurology.

In The Last Decade

Rimke C. Vos

100 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rimke C. Vos Netherlands 26 709 437 266 263 246 107 1.7k
Lisa Riste United Kingdom 21 590 0.8× 246 0.6× 367 1.4× 330 1.3× 204 0.8× 45 2.8k
Jordi Real Spain 22 462 0.7× 307 0.7× 117 0.4× 161 0.6× 135 0.5× 118 1.7k
Lars Pieper Germany 25 470 0.7× 461 1.1× 113 0.4× 165 0.6× 369 1.5× 91 2.0k
Blair Anton United States 12 592 0.8× 210 0.5× 427 1.6× 290 1.1× 44 0.2× 24 1.9k
Henk Asscheman Netherlands 29 1.2k 1.7× 276 0.6× 153 0.6× 77 0.3× 339 1.4× 46 3.7k
Kevin L. Sloan United States 22 601 0.8× 501 1.1× 230 0.9× 264 1.0× 205 0.8× 40 1.8k
Cheryl Vigen United States 23 173 0.2× 156 0.4× 369 1.4× 222 0.8× 91 0.4× 73 1.9k
Iftekhar Kalsekar United States 25 485 0.7× 157 0.4× 205 0.8× 106 0.4× 79 0.3× 99 1.7k
Jannicke Igland Norway 29 401 0.6× 258 0.6× 301 1.1× 198 0.8× 187 0.8× 138 2.5k
Alison Hayes Australia 25 578 0.8× 362 0.8× 215 0.8× 515 2.0× 97 0.4× 103 2.2k

Countries citing papers authored by Rimke C. Vos

Since Specialization
Citations

This map shows the geographic impact of Rimke C. Vos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rimke C. Vos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rimke C. Vos more than expected).

Fields of papers citing papers by Rimke C. Vos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rimke C. Vos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rimke C. Vos. The network helps show where Rimke C. Vos may publish in the future.

Co-authorship network of co-authors of Rimke C. Vos

This figure shows the co-authorship network connecting the top 25 collaborators of Rimke C. Vos. A scholar is included among the top collaborators of Rimke C. Vos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rimke C. Vos. Rimke C. Vos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blom, Marieke T., Petra Denig, Ron M. C. Herings, et al.. (2025). Feasibility of implementing an intervention in general practice for deprescribing of glucose-lowering medication in overtreated elderly. Family Practice. 42(5).
2.
3.
Groenwold, Rolf H. H., et al.. (2024). External validation of SCORE2-Diabetes in The Netherlands across various socioeconomic levels in native-Dutch and non-Dutch populations. European Journal of Preventive Cardiology. 32(7). 555–563. 4 indexed citations
4.
Zutphen, Tim van, et al.. (2024). Development and validation of a Context-sensitive Positive Health Questionnaire (CPHQ): A factor analysis and multivariate regression study. Journal of Patient-Reported Outcomes. 8(1). 44–44. 3 indexed citations
5.
Geelhoed-Duijvestijn, Petronella, et al.. (2024). The development and progression of albuminuria in South Asians with type 2 diabetes compared with Western Europeans. Results from the HinDu the Hague diabetes study. Diabetic Medicine. 42(3). e15454–e15454. 1 indexed citations
6.
Hageman, Steven H J, Laurens van Gestel, Tobias Bonten, et al.. (2024). From reactive to proactive preventive cardiovascular risk management in primary care: a feasibility study. European Journal of Preventive Cardiology. 31(Supplement_1). 1 indexed citations
7.
Sep, Simone J. S., Carla Kallen, Marleen M. J. van Greevenbroek, et al.. (2023). Sex comparisons in the association of prediabetes and type 2 diabetes with cognitive function, depression, and quality of life: The Maastricht study. Diabetic Medicine. 40(7). e15115–e15115. 6 indexed citations
8.
Vos, Rimke C., et al.. (2023). Implicit gender bias in the diagnosis and treatment of type 2 diabetes: A randomized online study. Diabetic Medicine. 40(8). e15087–e15087. 3 indexed citations
9.
Seidu, Samuel, et al.. (2023). The impact of the covid-19 pandemic on diabetes care: the perspective of healthcare providers across Europe. Primary care diabetes. 17(2). 141–147. 4 indexed citations
10.
11.
12.
Jong, Marit de, Sanne A. E. Peters, Carla Kallen, et al.. (2021). Sex Disparities in Cardiovascular Risk Factor Assessment and Screening for Diabetes-Related Complications in Individuals With Diabetes: A Systematic Review. Frontiers in Endocrinology. 12. 617902–617902. 3 indexed citations
13.
Corbee, Ronald Jan, Floor M. Kroese, Denise T. D. de Ridder, et al.. (2020). Discussing overweight in children during a regular consultation in general practice: a qualitative study. BMC Family Practice. 21(1). 18–18. 4 indexed citations
14.
Hart, Huberta E., Guy E.H.M. Rutten, Esther de Groot, et al.. (2019). <p>De-Intensification Of Blood Glucose Lowering Medication In People Identified As Being Over-Treated: A Mixed Methods Study</p>. Patient Preference and Adherence. Volume 13. 1775–1783. 11 indexed citations
15.
16.
Vos, Rimke C., et al.. (2018). Cluster randomised trial on the effectiveness of a computerised prompt to refer (back) patients with type 2 diabetes. PLoS ONE. 13(12). e0207653–e0207653. 2 indexed citations
17.
18.
Vos, Rimke C., et al.. (2018). Disentangling the effect of illness perceptions on health status in people with type 2 diabetes after an acute coronary event. BMC Family Practice. 19(1). 35–35. 13 indexed citations
19.
Ketelaar, Marjolijn, Olaf Verschuren, Jan Willem Gorter, et al.. (2015). Efficacy of three therapy approaches in preschool children with cerebral palsy: a randomized controlled trial. Developmental Medicine & Child Neurology. 58(7). 758–766. 19 indexed citations
20.
Vos, Rimke C., et al.. (2011). The influence of an educational program on the HbA1c-level of adolescents with type 1 diabetes mellitus: a retrospective study. Journal of Pediatric Endocrinology and Metabolism. 24(1-2). 15–9. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lisa Riste Breakdown of academic impact, for papers by Jordi Real Breakdown of academic impact, for papers by Lars Pieper Breakdown of academic impact, for papers by Blair Anton Breakdown of academic impact, for papers by Henk Asscheman Breakdown of academic impact, for papers by Kevin L. Sloan Breakdown of academic impact, for papers by Cheryl Vigen Breakdown of academic impact, for papers by Iftekhar Kalsekar Breakdown of academic impact, for papers by Jannicke Igland Breakdown of academic impact, for papers by Alison Hayes
Rankless by CCL
2026